Educational intervention to improve outcomes of patients with diabetes debut and a history of hypertension
Keywords:
diabetes mellitus, type 2, angiotensin-converting enzyme inhibitors, life styleAbstract
The main cause of death of the person with type 2 diabetes mellitus is cardiovascular. Its prevention involves an integrated management of all risk factors.Objective: To evaluate the results of an intervention to improve the outcome of patients with type 2 diabetes debut and a history of hypertension that were treated with betablockers at the Chiqui Lubián Gomez University Polyclinic.
Material and Method: prospective quasi-experimental study in an intentional sample of 22 patients with type 2 diabetes mellitus debut and a history of hypertension who attended the multidisciplinary consultation of diabetes mellitus in the period from January to December 2011.
Results: there was a prevalence of female patients -16 patients (72.7%) - and the age group between 50 and 69 years - (77.2%). The hypertension control was achieved with a change to inhibitors of angiotensin converting enzyme (90.9%). Metabolic control, by quarter, improved significantly until reaching a 95.4% in the last one. Favorable changes in lifestyle, such as incorporating the practice of physical exercises (81.8%), were achieved. They ensure a better quality of life. With regard to body weight, at the start of the intervention there were 12 (54.5%) overweight patients and at the end they were reduced to seven (31.8%). It was possible that 100% of patients had a proper diet to control the disease, but only one patient (18.1%) stopped smoking, which is not significant. Better results could be achieved in the long term. Generally, the intervention was successful in 90.9% of patients.
Conclusions: Patients presenting with type 2 diabetes mellitus and a history of hypertension evolve favorably with a treatment of angiotensin converting enzyme inhibitors as hypotensive and good metabolic control with lifestyle changes.
Downloads
Downloads
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).